Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
trial   source : Www.daxor.com    save search
Daxor Corporation To Present Compelling New Data and Clinical Trials Utilizing the BVA-100® Blood Test at the Heart Failure Society of America Annual Scientific Meeting 2021
Published: 2021-09-08 (Crawled : 14:00) - daxor.com
DXR | $9.74 0.73% 8.3K twitter stocktwits trandingview |
Health Technology
 | | O: -2.52% H: 6.29% C: 2.78%
blood heart clinical trials test trials trial
Daxor Corporation Receives National Institutes of Health (NIH) Funding Notification for Landmark Multi-Center Heart Failure Trial Utilizing the BVA-100® (Blood Volume Analyzer) with the United States Department of Veterans Affairs
Published: 2021-05-06 (Crawled : 12:00) - daxor.com
DXR | $9.74 0.73% 8.3K twitter stocktwits trandingview |
Health Technology
 | | O: 6.38% H: 0.0% C: -5.84%
funding blood heart trial
Gainers vs Losers
67% 33%

Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.